Evidence map›Paper›PMID 42494401›Full record

ArticleFrontiers in neurology

A victim of its own progress: why the success of modern therapeutics forces a re-evaluation of placebo-controlled trials in migraine prevention.

Nirit Lev, Leah Borovoi, Emily Elefant, Erel Domany, Oved Daniel, Gal Ifergane

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nirit LevDepartment of Neurology, Meir Medical Center, Clalit Health Services, Kfar Saba, Israel.
Leah BorovoiAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Emily ElefantDepartment of Neurology, Meir Medical Center, Clalit Health Services, Kfar Saba, Israel.
Erel DomanyDepartment of Neurology, Rambam Health Care Campus, Haifa, Israel.
Oved DanielNeurology Division, Tel Aviv Sourasky University Medical Center (Ichilov), Affiliated to the Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv-Yafo, Israel.
Gal IferganeDepartment of Neurology and Clinical Research Center, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

calcitonin gene-related peptide (CGRP)clinical trial designdeclaration of Helsinkimigraineneuroethicsplaceboplacebo-controlled trials

Identifiers

PMID42494401
PMCPMC13393417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.